Kerri Hensley

Kerri Hensley is a Clinical Genomics Scientist at Myriad Genetics since April 2018, specializing in the interpretation and classification of genetic variants related to inherited cancer and expanded carrier screening assays. Kerri manages team projects focused on developing and streamlining curation procedures and expanding assay panels. Before this role, Kerri served as a Variant Curation Scientist at Counsyl and a Scientist at Quest Diagnostics, where significant contributions included the design and launch of Next Generation Sequencing assays. Kerri's career began at Chiron Corporation as a QA Specialist, ensuring compliance with FDA regulations. Kerri holds a Master of Science in Genetics from the University of California, Davis, and a Bachelor of Science in Microbiology and Molecular Genetics from UCLA.